000 01531 a2200457 4500
005 20250511181314.0
264 0 _c19921008
008 199210s 0 0 eng d
022 _a0014-2999
024 7 _a10.1016/0014-2999(92)90615-b
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSjöholm, B
245 0 0 _aCharacterization of [3H]atipamezole as a radioligand for alpha 2-adrenoceptors.
_h[electronic resource]
260 _bEuropean journal of pharmacology
_cApr 1992
300 _a109-17 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdrenergic alpha-Antagonists
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aAnimals, Newborn
_xmetabolism
650 0 4 _aBlood Platelets
_xmetabolism
650 0 4 _aCerebral Cortex
_xmetabolism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImidazoles
_xmetabolism
650 0 4 _aKinetics
650 0 4 _aLung
_xmetabolism
650 0 4 _aMale
650 0 4 _aMembranes
_xmetabolism
650 0 4 _aRadioligand Assay
650 0 4 _aRats
650 0 4 _aRats, Inbred Strains
650 0 4 _aReceptors, Adrenergic, alpha
_xmetabolism
650 0 4 _aTritium
650 0 4 _aYohimbine
_xmetabolism
700 1 _aVoutilainen, R
700 1 _aLuomala, K
700 1 _aSavola, J M
700 1 _aScheinin, M
773 0 _tEuropean journal of pharmacology
_gvol. 215
_gno. 1
_gp. 109-17
856 4 0 _uhttps://doi.org/10.1016/0014-2999(92)90615-b
_zAvailable from publisher's website
999 _c1361938
_d1361938